This improvement was accompanied by a significant reduction in high-sensitivity CRP concentration, suggesting that the antiinflammatory effects of GLP-1 medicines may contribute to or be independently associated with their benefits in OSA. Here, CRP is linked to obstructive sleep apnea syndrome.